Qualitative assessment of nasopharyngeal aspirates as an alternative to tracheal aspirates in extremely preterm infants - Report - MDSpire

Qualitative assessment of nasopharyngeal aspirates as an alternative to tracheal aspirates in extremely preterm infants

  • By

  • Fernando Garrido-Muñoz

  • Alejandro Fernández-Vega

  • Rebeca Gregorio-Hernández

  • Alberto Trujillo-Fagundo

  • Almudena Alonso-Ojembarrena

  • June 10, 2026

  • 0 min

Share

Clinical Report: Evaluation of Nasopharyngeal Aspirates in Preterm Infants

Overview

This study evaluates nasopharyngeal aspirates (NPAs) as a noninvasive alternative to tracheal aspirates (TAs) for respiratory biomarker research in extremely preterm infants. Findings indicate that NPAs can provide valuable proteomic data relevant to lung pathologies, potentially enhancing patient recruitment and reducing the risks associated with invasive sampling methods.

Background

Extremely preterm infants are at high risk for respiratory diseases, including bronchopulmonary dysplasia (BPD), which can lead to significant long-term health issues. Traditional invasive sampling methods, while providing high specificity, pose risks to these vulnerable patients. The exploration of noninvasive sampling techniques, such as nasopharyngeal aspiration, is crucial for advancing research while minimizing harm to this population.

Data Highlights

Sample TypeProteins IdentifiedFunctional Proteomic Hits
Nasopharyngeal Aspirates6492,937
Tracheal AspiratesVariedVaried

Key Findings

  • NPAs and TAs shared 649 proteins, with 392 (60.4%) specific to lung cells related to preterm lung pathologies.
  • Enrichment analysis showed similarities in biological processes, molecular functions, and cellular components between NPA and TA samples.
  • NPA proteins were enriched in terms related to the epithelium, while TA proteins were specific to lung tissue.
  • The study supports the potential of NPAs for lung biomarker research in preterm neonates.
  • Noninvasive sampling methods may improve patient recruitment for studies on respiratory diseases.

Clinical Implications

The findings suggest that nasopharyngeal aspirates can be a viable alternative to tracheal aspirates for biomarker discovery in extremely preterm infants. This approach may enhance research capabilities while reducing the risks associated with invasive procedures.

Conclusion

Nasopharyngeal aspirates represent a promising noninvasive method for obtaining respiratory biomarkers in preterm infants, potentially facilitating better research outcomes and patient care.

Related Resources & Content

  1. Frontiers in Pediatrics, 2026 -- Comparison of Nasal Intermittent Positive Pressure Ventilation and Continuous Positive Airway Pressure on Improving Bronchopulmonary Dysplasia Outcomes in Preterm Infants
  2. Intensive Care Medicine, 2012 -- Highlights from Intensive Care Medicine 2012: Focus on Noninvasive Ventilation, Patient Monitoring, Ventilator Interactions, Acute Respiratory Distress Syndrome, Sedation Practices, Pediatric Considerations, and Additional Topics
  3. Intensive Care Medicine, 2014 -- Highlights from Intensive Care Medicine in 2014: Focus on ARDS, Airway Management, Ventilation Strategies, Sepsis Adjuvants, Hepatic Failure, Symptom Evaluation and Treatment, Palliative Care for Families, Prognostic Factors, Organ Donation, Patient Outcomes, Healthcare Organization, and Research Approaches
  4. Neonatal Resuscitation Guidelines -- AAP, 2025 -- Neonatal Resuscitation Guidelines
  5. conexiant — Pediatric Nasal Foreign Bodies: Skip the OR? 
  6. Why this question matters now
  7. 79101675
  8. Lipidomic signatures of tracheal aspirate diagnostic biomarkers in preterm infants with bronchopulmonary dysplasia - PubMed

Original Source(s)

Related Content